Omada Health (OMDA)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | 89 | 123 | 170 | 260 | 310 | 339 |
| Operating profit | $m | -12 | -0 | ||||||
| Net profit | $m | - | - | -73 | -68 | -47 | -13 | 4 | 19 |
| EPS reported | $ | -0.22 | 0.06 | ||||||
| Operating cashflow per share | $ | 0.31 | 0.40 | ||||||
| Capex per share | $ | 0.02 | 0.02 | ||||||
| FCF per share | $ | 0.29 | 0.38 | ||||||
| Free cash flow | $m | 17 | 23 | ||||||
| Net debt | $m | -222 | -222 | ||||||
| Book value equity | $m | 230 | 253 | ||||||
| Book value per share | $ | 3.93 | 3.95 | ||||||
| Number of shares | m | 58.43 | 63.95 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 307.78 | ||||||
| P/B LTM | x | 4.01 | 3.65 | ||||||
| P/S LTM | x | 3.54 | 2.98 | ||||||
| P/FCF LTM | x | 54.46 | 40.52 | ||||||
| EV/EBITDA LTM | x | -147.27 | 59.56 | ||||||
| EV/Sales LTM | x | 2.69 | 3.90 | ||||||
| Earnings Yield LTM | % | -1.39% | +0.32% | ||||||
| FCF Yield | % | +1.84% | +2.47% | ||||||
| Quality | |||||||||
| ROE | % | -5.56% | +1.84% | ||||||
| ROIC | % | -5.21% | -0.18% | ||||||
| Operating margin | % | -4.60% | -0.15% | ||||||
| Gross margin | % | +65.69% | +68.19% | ||||||
| FCF/Sales | % | +6.51% | +7.35% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +53.24% | +82.43% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | - | - | ||||||
| Net Debt/EBITDA | x | 46.71 | -18.86 | ||||||
| EBIT/Net interest | x | -4.72 | -1.17 | ||||||
| Net debt/market cap | % | 0.00% | 0.00% | ||||||
| Net debt/Equity | x | -0.97 | -0.88 | ||||||
| Gross debt/equity | x | 0.00 | 0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free